Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Accumulated Expenses (2019 - 2025)

Bioadaptives' Other Accumulated Expenses history spans 6 years, with the latest figure at $1023.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $1023.0 for Q4 2025, changed 0.2% from a year ago — trailing twelve months through Dec 2025 was $1023.0 (changed 0.2% YoY), and the annual figure for FY2025 was $1023.0, changed 0.2%.
  • Other Accumulated Expenses for Q4 2025 was $1023.0 at Bioadaptives, roughly flat from $1018.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1023.0 in Q4 2025 to a low of $1015.0 in Q4 2022.
  • The 4-year median for Other Accumulated Expenses is $1019.0 (2023), against an average of $1019.4.
  • The sharpest move saw Other Accumulated Expenses increased 0.39% in 2023, then fell 0.39% in 2025.
  • Year by year, Other Accumulated Expenses stood at $1015.0 in 2022, then rose by 0.39% to $1019.0 in 2023, then increased by 0.2% to $1021.0 in 2024, then grew by 0.2% to $1023.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $1023.0, $1018.0, and $1019.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.